Hayek, Samah http://orcid.org/0000-0002-3300-1769
Levy, Joseph
Shaham, Galit
Dagan, Noa
Serby, Danielle
Duskin-Bitan, Hadar
Yarden, Adva
Ferreira, Cátia
Livnat, Idit
Dube, Sabada
Taylor, Sylvia
Venkatesan, Sudhir
Balicer, Ran D.
Netzer, Doron
Peretz, Alon
Funding for this research was provided by:
AstraZeneca
Article History
Received: 6 February 2024
Accepted: 15 April 2024
First Online: 10 May 2024
Declarations
:
: Samah Hayek, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Ran D. Balicer, Doron Netzer and Alon Peretz are employees of Clalit Health Services. Joseph Levy was an employee of Clalit Health Services at the time of this study and manuscript development; Dr Levy’s current affiliation is the Hebrew University of Jerusalem. Clalit Research Institute received funding from AstraZeneca to support execution of this study. Institutional grants to Clalit Research Institute from Pfizer outside the submitted work and unrelated to COVID-19, with no direct or indirect personal benefits. Adva Yarden, Cátia Ferreira, Idit Livnat, Sabada Dube, Sylvia Taylor and Sudhir Venkatesan are employees of, and hold or may hold stock in, AstraZeneca.
: This study used de-identified patient data and was approved by the Clalit Health Services institutional review board.